Dr. Tikly discusses the solutions to drug access challenges in South Africa in both state and private sectors 👇 🔸Off label use, buyouts, price⬇️, advocacy... Highly relatable because these are similar challenges we face in the PH @rheumarhyme @doktora_ging #ACR22 @rheumnow https://t.co/ajshylgtIE